News Summary
Mount Sinai Hospital in New York City has started using the FloPatch, a non-invasive wearable ultrasound device, to monitor patients post-surgery. This innovative technology aims to detect fluid overload, a common complication after surgeries and transplants, potentially reducing recovery costs and improving patient outcomes. The device, which costs approximately $450, could save the hospital significant expenses by preventing complications associated with fluid imbalances, thereby enhancing the quality of care provided to patients in the ICU.
New York City – Mount Sinai Hospital has begun using an innovative wearable ultrasound device known as FloPatch in its surgical and transplant intensive care unit (ICU) to better monitor patients post-surgery and potentially reduce recovery costs. This non-invasive device detects excess fluid in patients, a common and serious complication following surgical procedures and organ transplants.
Excess fluid accumulation can lead to extended stays in the ICU and poses an increased risk of mortality. The FloPatch device uses ultrasound waves to assess how the body responds to intravenous fluids, allowing medical staff to make informed decisions on patient care. In particular, patients with low blood pressure due to shock, often resulting from sepsis after organ transplants, can greatly benefit from this technology. Too much fluid in these patients can compromise recovery and overall outcomes.
Traditionally, measuring fluid levels in patients required invasive methods like transesophageal echocardiograms, which involve inserting a probe down the throat. However, the FloPatch device is non-invasive and can be easily applied by nurses and ICU fellows, who can then monitor vital patient data directly. This could lead to a significant improvement in patient care.
Manufactured by Flosonics Medical, a medtech company located in Sudbury, Ontario, the FloPatch device costs approximately $450 per unit. Implementing the device could save Mount Sinai about $15,000 for each patient by preventing the complications that arise from excess fluid.
Currently, Mount Sinai’s ICU treats around 150 patients annually who are at risk for fluid overload. If FloPatch proves successful, even a small fraction of these patients could justify the investment. The device measures blood flow through the carotid artery, a reliable indicator of a patient’s fluid responsiveness. Early trials have demonstrated that FloPatch correlates well with patients who are in shock due to sepsis, potentially allowing for quicker and more efficient treatment interventions.
As the only healthcare provider on the East Coast utilizing the FloPatch device, Mount Sinai stands at the forefront of a growing trend in precision medicine within critical care settings. The ability to monitor patients in real-time with the FloPatch could not only improve treatment targeting but also pave the way for personalized care strategies tailored to individual patient needs.
The immediate focus of incorporating the FloPatch device lies in its capacity to address complications due to fluid imbalance, which can result in serious setbacks post-surgery. By providing consistent, real-time data, the device hopes to minimize the incidence of adverse effects associated with fluid overload, ultimately leading to more favorable outcomes and reduced healthcare costs.
The introduction of this technology at Mount Sinai reflects a commitment to advancing patient care through innovative solutions that enhance monitoring capabilities and support clinical decision-making processes. As healthcare continues to evolve with the adoption of advanced monitoring tools like FloPatch, the overarching goal remains the same: to deliver the highest standard of care and improve the quality of life for patients navigating the challenges of recovery.
Deeper Dive: News & Info About This Topic
HERE Resources
Additional Resources
- Crain’s New York: Mount Sinai Adopts Flosonic Ultrasound
- Wikipedia: Ultrasound
- MassDevice: Flosonics Wearable Ultrasound New Hospital Deal
- Google Search: Flosonics Technology
- Business Wire: Sutter Health Hospitals Deploy Wearable Ultrasound Tech
- Google Scholar: Wearable Ultrasound Technology
- Gastroenterology & Endoscopy News: IBD Monitoring
- Encyclopedia Britannica: Medical Technology
Author: STAFF HERE NEW YORK WRITER
NEW YORK STAFF WRITER The NEW YORK STAFF WRITER represents the experienced team at HERENewYork.com, your go-to source for actionable local news and information in New York, the five boroughs, and beyond. Specializing in "news you can use," we cover essential topics like product reviews for personal and business needs, local business directories, politics, real estate trends, neighborhood insights, and state news affecting the area—with deep expertise drawn from years of dedicated reporting and strong community input, including local press releases and business updates. We deliver top reporting on high-value events such as New York Fashion Week, Macy's Thanksgiving Day Parade, and Tribeca Film Festival. Our coverage extends to key organizations like the Greater New York Chamber of Commerce and United Way of New York, plus leading businesses in finance and media that power the local economy such as JPMorgan Chase, Goldman Sachs, and Bloomberg. As part of the broader HERE network, including HEREBuffalo.com, we provide comprehensive, credible insights into New York's dynamic landscape.
